ggl cap-gat_torace (1)

Upload: elena-daniela-burca

Post on 07-Jul-2018

217 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/18/2019 Ggl Cap-gat_torace (1)

    1/3

  • 8/18/2019 Ggl Cap-gat_torace (1)

    2/3

    The lymphatic system, shown in green, is important for immunity.

    Impact of manual lymphatic drainage on

    hemodynamic parameters in patients with

    heart failure and lower limb edema.

    Leduc O, Crasset V, Leleu C, Baptiste N, Koziel , !elahaie C, "astouret #, $ilputte #,

    Leduc .

    Source

    %aute &cole ".%. 'paa(, Lympho)"hle*ology +nit, Brussels. oleducs(ynet.*e

    Abstract

    -anual lymphatic drainage -L!/, intermittent se0uential pneumatic therapy 1'"T/,

    multilayered *andages -LB/, and compression garments are main techni0ues in

    conser2ati2e treatment of peripheral lymphedema. 'ince 3445, it has *een thought that 1'"T

    applied to *oth lower lim*s simultaneously should not *e used for patients with heart failure

     *ecause right atrial, pulmonary arterial, and pulmonary wedge pressures may increase to a

    critical point. 1n 6557, these same results were o*ser2ed in patients with heart failure wearing

    -LB. #or these reasons, -LB and 1'"T ha2e *een contraindicated during lymphedema

    treatment in cardiac patients. The aim of this study was to determine if we may continue the

    treatment of lower lim* lymphedema using -L! in patients with heart failure. $e e2aluated

    hemodynamic parameters using echography during -L! in patients with cardiac disease ando*tained circumferential measurements of the edematous lim* *efore and after treatment.

    http://www.ncbi.nlm.nih.gov/pubmed?term=Leduc%20O%5BAuthor%5D&cauthor=true&cauthor_uid=21667818http://www.ncbi.nlm.nih.gov/pubmed?term=Crasset%20V%5BAuthor%5D&cauthor=true&cauthor_uid=21667818http://www.ncbi.nlm.nih.gov/pubmed?term=Crasset%20V%5BAuthor%5D&cauthor=true&cauthor_uid=21667818http://www.ncbi.nlm.nih.gov/pubmed?term=Crasset%20V%5BAuthor%5D&cauthor=true&cauthor_uid=21667818http://www.ncbi.nlm.nih.gov/pubmed?term=Leleu%20C%5BAuthor%5D&cauthor=true&cauthor_uid=21667818http://www.ncbi.nlm.nih.gov/pubmed?term=Baptiste%20N%5BAuthor%5D&cauthor=true&cauthor_uid=21667818http://www.ncbi.nlm.nih.gov/pubmed?term=Baptiste%20N%5BAuthor%5D&cauthor=true&cauthor_uid=21667818http://www.ncbi.nlm.nih.gov/pubmed?term=Koziel%20A%5BAuthor%5D&cauthor=true&cauthor_uid=21667818http://www.ncbi.nlm.nih.gov/pubmed?term=Koziel%20A%5BAuthor%5D&cauthor=true&cauthor_uid=21667818http://www.ncbi.nlm.nih.gov/pubmed?term=Delahaie%20C%5BAuthor%5D&cauthor=true&cauthor_uid=21667818http://www.ncbi.nlm.nih.gov/pubmed?term=Delahaie%20C%5BAuthor%5D&cauthor=true&cauthor_uid=21667818http://www.ncbi.nlm.nih.gov/pubmed?term=Delahaie%20C%5BAuthor%5D&cauthor=true&cauthor_uid=21667818http://www.ncbi.nlm.nih.gov/pubmed?term=Pastouret%20F%5BAuthor%5D&cauthor=true&cauthor_uid=21667818http://www.ncbi.nlm.nih.gov/pubmed?term=Wilputte%20F%5BAuthor%5D&cauthor=true&cauthor_uid=21667818http://www.ncbi.nlm.nih.gov/pubmed?term=Wilputte%20F%5BAuthor%5D&cauthor=true&cauthor_uid=21667818http://www.ncbi.nlm.nih.gov/pubmed?term=Leduc%20A%5BAuthor%5D&cauthor=true&cauthor_uid=21667818http://www.ncbi.nlm.nih.gov/pubmed?term=Crasset%20V%5BAuthor%5D&cauthor=true&cauthor_uid=21667818http://www.ncbi.nlm.nih.gov/pubmed?term=Leleu%20C%5BAuthor%5D&cauthor=true&cauthor_uid=21667818http://www.ncbi.nlm.nih.gov/pubmed?term=Baptiste%20N%5BAuthor%5D&cauthor=true&cauthor_uid=21667818http://www.ncbi.nlm.nih.gov/pubmed?term=Koziel%20A%5BAuthor%5D&cauthor=true&cauthor_uid=21667818http://www.ncbi.nlm.nih.gov/pubmed?term=Delahaie%20C%5BAuthor%5D&cauthor=true&cauthor_uid=21667818http://www.ncbi.nlm.nih.gov/pubmed?term=Pastouret%20F%5BAuthor%5D&cauthor=true&cauthor_uid=21667818http://www.ncbi.nlm.nih.gov/pubmed?term=Wilputte%20F%5BAuthor%5D&cauthor=true&cauthor_uid=21667818http://www.ncbi.nlm.nih.gov/pubmed?term=Leduc%20A%5BAuthor%5D&cauthor=true&cauthor_uid=21667818http://www.ncbi.nlm.nih.gov/pubmed?term=Leduc%20O%5BAuthor%5D&cauthor=true&cauthor_uid=21667818

  • 8/18/2019 Ggl Cap-gat_torace (1)

    3/3

    -L! treatment significantly decreased the lim*s as e8pected. The heart rate also decreased

    following -L! in contrast with all other hemodynamic parameters which were not affected

     *y -L!. The findings suggest that there is no contraindication to use -L! in patients with

    heart failure and lower lim* edema.

    http://books.google.ro/books?

    id=NjLNYMNTAqIC&pg=PA2!&lpg=PA2!&dq="#$%#ll'"ph#ti(dr#i$#gele

    d%(&so%r(e=bl&ots=)*+(j#2r,-&sig=o,sslb%qPr0*132M40562k&hl=ro&s

    #=,&ei=7Yld8#LY79TtA#rI5gA;&